公开(公告)号：US20160361367A1

公开(公告)日：2016-12-15

申请号：US15178907

申请日：2016-06-10

Applicant: Mi Kyung HA

Inventor： Mi Kyung HA

IPC: A61K35/586 ,  A61K36/638 ,  A61K36/88 ,  A61K36/234 ,  A61K36/815 ,  A61K36/804 ,  A61K36/8965 ,  A61K36/40 ,  A61K36/77

CPC classification number: A61K35/586 ,  A61K9/0048 ,  A61K9/08 ,  A61K36/234 ,  A61K36/40 ,  A61K36/638 ,  A61K36/77 ,  A61K36/804 ,  A61K36/815 ,  A61K36/88 ,  A61K36/8965 ,  A61K47/46 ,  A61K2236/00 ,  A61K2300/00

Abstract: The present invention relates to a pharmacopuncture composition for eye health that includes medicinal materials beneficial to the improvement of eye health and a method for manufacturing the same that is conducted according to the characteristics of the medicinal materials. The pharmacopuncture composition includes a mixed extract obtained from Cornic fructus, Ligustri fructus, Acori rhizome, Euphoria longana, Lycii fructus, Rehmanniae radix, Asparagi tuber, and Cnidii rhizoma through a water bath and mixed with a Testudinis carapax concentrated liquid.

Abstract translation: 本发明涉及一种用于眼睛健康的药效学组合物，其包括有益于改善眼睛健康的药用材料及其制造方法，其根据药物特性进行。 药草组合物包括通过水浴从Cornic fructus，Ligustri fructus，Acori rhizome，Euphoria longana，Lycii fructus，Rehmanniae radix，Asparagi tuber和Cnidii rhizoma获得的混合提取物，并与卡拉OK浓缩液混合。

公开(公告)号：US20210169961A1

公开(公告)日：2021-06-10

申请号：US17265724

申请日：2018-12-18

Applicant: SHUGUANG HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE ,  ACADEMY OF MILITARY MEDICAL SCIENCES ,  SHANGHAI SANG LUO MEDICINE TECHNOLOGY CO., LTD.

Inventor： Yueqiu Gao ,  Junjie Shan ,  Xuehua Sun ,  Man Li ,  Yanxu Chen ,  Zhenhua Zhou ,  Yating Gao ,  Hao Ma ,  Xin Zhang ,  Rui Xu ,  Dan Nie ,  Lulu Liu ,  Changwei Li ,  Yu Yang ,  Xiunan Zhao

IPC: A61K36/746 ,  A61K36/074 ,  A61K36/481 ,  A61K36/71 ,  A61K36/489 ,  A61K36/537 ,  A61K36/296 ,  A61K36/64 ,  A61K36/284 ,  A61K36/752 ,  A61K36/41 ,  A61K36/488 ,  A61K36/72 ,  A61K36/53 ,  A61K36/9066 ,  A61K35/586 ,  A61K36/8984 ,  A61K36/898 ,  A61K36/48 ,  A61K36/539 ,  A61K9/00 ,  A61K9/16 ,  A61K9/20 ,  A61K9/48 ,  A61P31/20 ,  A61P1/16 ,  A61P35/00 ,  A61K31/522 ,  A61K31/683 ,  A61K31/7072 ,  A61K31/506 ,  A23L33/105 ,  A23L33/00

Abstract: Disclosed is a hepatoprotective traditional Chinese medicine composition, extract and pharmaceutical use thereof. The composition comprises Morinda officinalis How, Ganoderma lucidum (Leyss. Ex Fr.) Karst., Astragalus membranaceus (Fisch) Bge. Var. monghlicus (Bge) Hsiao, Ranunculus ternatus Thunb., Sophora flavescens Alt. and Salvia miltiorrhiza Bge. The composition and extract thereof may be used for treating liver injury, hepatitis, hepatic fibrosis, hepatic cirrhosis or liver cancer, and they may also be used as a vaccine adjuvant or an immunomodulator.

公开(公告)号：US20200261527A1

公开(公告)日：2020-08-20

申请号：US16858352

申请日：2020-04-24

Applicant: Shui Yin Lo

Inventor： Shui Yin Lo

IPC: A61K36/481 ,  A61K35/32 ,  A61K33/42 ,  A61K31/203 ,  A61K36/18 ,  A61K36/232 ,  A61K31/59 ,  A61K31/51 ,  A61K31/4418 ,  A61K33/22 ,  A61K35/64 ,  A61K33/30 ,  A61K35/644 ,  A61K35/586 ,  A61K33/06

Abstract: A hybrid herbal and drug composition includes an amount of Chinese herb about 0.01 to 5% by weight of the composition; an amount of animal-based matter about 0.01 to 5% by weight of the composition; an amount of vitamin about 0.01 to 5% by weight of the composition; an amount of mineral about 0.01 to 5% by weight of the composition; an amount of hormone about 0.01 to 5% by weight of the composition; an amount of factory produced product about 0.01 to 5% by weight of the composition; and an amount of the purified water about 70% to 99.94% by weight of the composition.

公开(公告)号：US20180099021A1

公开(公告)日：2018-04-12

申请号：US15573269

申请日：2016-02-26

Applicant: Jian MA

Inventor： Jian MA

IPC: A61K36/899 ,  A61K35/586 ,  A61K35/646 ,  A61K35/62 ,  A61P35/00

CPC classification number: A61K36/899 ,  A61K35/586 ,  A61K35/62 ,  A61K35/646 ,  A61P35/00

Abstract: Disclosed is a topical drug for treating breast cancer and preparation method thereof. The topical drug comprises the following ingredients in parts by weight: 5-10 parts of Astragalus, 3-5 parts of Oldenlandia diffusa, 3-5 parts of dandelion, 5-10 parts of Lycoris radiate, 5-8 parts of Carapax trionycis, 3-5 parts of Pinellia pedatisecta, 2-3 parts of Acorus calamus, 3-5 parts of Ferula sinkiangensis, 3-5 parts of doubleteeth pubescent angelica root, 4-6 parts of Cryptotaenia japonica Hassk, 3-5 parts of Whitmania pigra Whitman, 5-8 parts of Wedelia chinensis, 6-8 parts of Echinacea purpurea, 4-6 parts of Folium Eriobotryae, 3-5 parts of Sedum sarmentosum, 5-10 parts of Angelicae sinensis, 2-5 parts of asparagus, 2-3 parts of scorpio, 5-8 parts of Rubia cordifolia L., 2-3 parts of alfalfa extract, 3-5 parts of extract of Jew's ear from mulberry trees, 5-7 parts of myrrh, 3-6 parts of nutgrass galingale rhizome and 3-5 parts of pericarpium citri reticulatae viride.

公开(公告)号：US20230158092A1

公开(公告)日：2023-05-25

申请号：US17990699

申请日：2022-11-20

Applicant: Ming Jie WU

Inventor： Ming Jie WU

IPC: A61K36/428 ,  A61K36/75 ,  A61K36/758 ,  A61K36/062 ,  A61K36/288 ,  A61K36/539 ,  A61K36/537 ,  A61K36/9066 ,  A61K36/90 ,  A61K36/79 ,  A61K36/233 ,  A61K36/074 ,  A61K36/258 ,  A61K35/586 ,  A23L33/105

CPC classification number: A61K36/428 ,  A61K36/75 ,  A61K36/758 ,  A61K36/062 ,  A61K36/288 ,  A61K36/539 ,  A61K36/537 ,  A61K36/9066 ,  A61K36/90 ,  A61K36/79 ,  A61K36/233 ,  A61K36/074 ,  A61K36/258 ,  A61K35/586 ,  A23L33/105

Abstract: The invention provides unique compositions containing mixtures of extracts from medicinal plants and animal parts, as well as related uses for improving health and treating diseases. The inventive compositions provide a wide range of health benefits in the human body in comparison to effects from individual components contained therein.

公开(公告)号：US11331361B2

公开(公告)日：2022-05-17

申请号：US16858352

申请日：2020-04-24

Applicant: Shui Yin Lo

Inventor： Shui Yin Lo

IPC: A61K36/00 ,  A61K36/481 ,  A61K35/32 ,  A61K33/42 ,  A61K31/203 ,  A61K36/18 ,  A61K36/232 ,  A61K31/59 ,  A61K31/51 ,  A61K31/4418 ,  A61K33/22 ,  A61K35/64 ,  A61K33/30 ,  A61K35/644 ,  A61K35/586 ,  A61K33/06

Abstract: A hybrid herbal and drug composition includes an amount of Chinese herb about 0.01 to 5% by weight of the composition; an amount of animal-based matter about 0.01 to 5% by weight of the composition; an amount of vitamin about 0.01 to 5% by weight of the composition; an amount of mineral about 0.01 to 5% by weight of the composition; an amount of hormone about 0.01 to 5% by weight of the composition; an amount of factory produced product about 0.01 to 5% by weight of the composition; and an amount of the purified water about 70% to 99.94% by weight of the composition.

公开(公告)号：US10265369B2

公开(公告)日：2019-04-23

申请号：US15573269

申请日：2016-02-26

Applicant: Jian Ma

Inventor： Jian Ma

IPC: A61K36/00 ,  A61K36/899 ,  A61K35/586 ,  A61P35/00 ,  A61K35/62 ,  A61K35/646

Abstract: Disclosed is a topical drug for treating breast cancer and preparation method thereof. The topical drug comprises the following ingredients in parts by weight: 5-10 parts of Astragalus, 3-5 parts of Oldenlandia diffusa, 3-5 parts of dandelion, 5-10 parts of Lycoris radiate, 5-8 parts of Carapax trionycis, 3-5 parts of Pinellia pedatisecta, 2-3 parts of Acorus calamus, 3-5 parts of Ferula sinkiangensis, 3-5 parts of doubleteeth pubescent angelica root, 4-6 parts of Cryptotaenia japonica Hassk, 3-5 parts of Whitmania pigra Whitman, 5-8 parts of Wedelia chinensis, 6-8 parts of Echinacea purpurea, 4-6 parts of Folium Eriobotryae, 3-5 parts of Sedum sarmentosum, 5-10 parts of Angelicae sinensis, 2-5 parts of asparagus, 2-3 parts of scorpio, 5-8 parts of Rubia cordifolia L., 2-3 parts of alfalfa extract, 3-5 parts of extract of Jew's ear from mulberry trees, 5-7 parts of myrrh, 3-6 parts of nutgrass galingale rhizome and 3-5 parts of pericarpium citri reticulatae viride.

公开(公告)号：US10857194B2

公开(公告)日：2020-12-08

申请号：US16275778

申请日：2019-02-14

Applicant: Shui Yin Lo

Inventor： Shui Yin Lo

IPC: A61K36/00 ,  A61K36/481 ,  A61K35/32 ,  A61K33/42 ,  A61K31/203 ,  A61K36/18 ,  A61K36/232 ,  A61K31/59 ,  A61K31/51 ,  A61K31/4418 ,  A61K33/22 ,  A61K35/64 ,  A61K33/30 ,  A61K35/644 ,  A61K35/586 ,  A61K33/06

Abstract: A hybrid herbal and drug composition includes an amount of Chinese herb about 0.01 to 5% by weight of the composition; an amount of animal-based matter about 0.01 to 5% by weight of the composition; an amount of vitamin about 0.01 to 5% by weight of the composition; an amount of mineral about 0.01 to 5% by weight of the composition; an amount of hormone about 0.01 to 5% by weight of the composition; an amount of factory produced product about 0.01 to 5% by weight of the composition; and an amount of the purified water about 70% to 99.94% by weight of the composition.

公开(公告)号：US10702557B2

公开(公告)日：2020-07-07

申请号：US16198870

申请日：2018-11-22

Applicant: Shaanxi Jianhua Biopharmaceutical Co., Ltd.

Inventor： Jian He ,  Hua Wang

IPC: A61K36/00 ,  A61K35/57 ,  A61K35/62 ,  A61K36/8966 ,  A61K36/902 ,  A61K36/904 ,  A61K36/8969 ,  A61K36/9066 ,  A61K35/618 ,  A61K35/63 ,  A61K35/586 ,  A61K35/12 ,  A61P17/00 ,  A61P13/08 ,  A61K9/00 ,  A61K35/64 ,  A61K36/076 ,  A61K36/39 ,  A61K36/40 ,  A61K36/481 ,  A61K36/64 ,  A61K36/65 ,  A61K36/884 ,  A61K36/894 ,  A61K45/06

Abstract: The invention provides a combined external medicine for treating prostate diseases and a method using the same. The combined external medicine includes a pre-immune composition comprising multi-immune powder and a noble bottle tree decoction, a lesion active composition comprising the multi-immune powder and a first medical decoction prepared from a first Chinese medical composition for treating prostate diseases, and a double rib active composition comprising the multi-immune powder and a second medical decoction prepared from a second Chinese medical composition for conditioning liver and kidney. The method includes applying the pre-immune composition on skin of lesion part and skin of the left and right ribs; waiting for 5-10 minutes; applying the lesion active composition and the double rib active composition on the skin of the lesion part and skin of the left and right ribs; and airing for 10-40 minutes.

公开(公告)号：US20190192603A1

公开(公告)日：2019-06-27

申请号：US15967045

申请日：2018-04-30

Applicant: Zhonghua CI

Inventor： Zhonghua CI

IPC: A61K36/64 ,  A61K36/65 ,  A61K36/232 ,  A61K36/533 ,  A61K36/736 ,  A61K36/28 ,  A61K36/484 ,  A61K36/752 ,  A61K36/346 ,  A61K36/738 ,  A61K35/586 ,  A61K47/26 ,  A61K45/06 ,  A61K9/00 ,  A61P7/00

CPC classification number: A61K36/64 ,  A61K9/0053 ,  A61K35/586 ,  A61K36/232 ,  A61K36/28 ,  A61K36/346 ,  A61K36/484 ,  A61K36/533 ,  A61K36/65 ,  A61K36/736 ,  A61K36/738 ,  A61K36/752 ,  A61K45/06 ,  A61K47/26 ,  A61K2236/13 ,  A61K2236/51 ,  A61P7/00

Abstract: The present application discloses a Chinese herbal oral paste for conditioning blood stasis constitution. The Chinese herbal oral paste includes the following components: unprocessed rehmannia root, peony root, angelica, sichuan lovage rhizome, motherwort herb, peach seed, safflower, licorice, orange fruit, platycodon root, twotoothed achyranthes root, rose flower, cortex moutan, kudzu vine root, nutgrass galingale rhizome, unprocessed cattail pollen, Chinese cinnamon, earthworm, suberect spatholobus stem, largeleaf gentian root, milkvetch root, snakegourd root, danshen root, sanqi powder, India madder root, unprocessed hawthorn fruit, donkey-hide gelatin, turtle shell gelatin, tortoise-plastron gelatin, xylitol, and stir-baked squama manitis. The Chinese herbal oral paste of the present disclosure has a higher drug concentration and good taste, is particularly suitable for health preserving in winter and conditioning the blood stasis constitution, will not create negative effects or harm to the human body at all, and is capable of achieving certain efficacy of strengthening physical health.